Melqart Asset Management (Uk) LTD Viking Therapeutics, Inc. Transaction History
Melqart Asset Management (Uk) LTD
- $1.03 Billion
- Q3 2024
A detailed history of Melqart Asset Management (Uk) LTD transactions in Viking Therapeutics, Inc. stock. As of the latest transaction made, Melqart Asset Management (Uk) LTD holds 94,107 shares of VKTX stock, worth $3.87 Million. This represents 0.58% of its overall portfolio holdings.
Number of Shares
94,107
Previous 114,947
18.13%
Holding current value
$3.87 Million
Previous $6.09 Million
2.23%
% of portfolio
0.58%
Previous 0.52%
Shares
2 transactions
Others Institutions Holding VKTX
# of Institutions
473Shares Held
65.6MCall Options Held
5.72MPut Options Held
3.39M-
Vanguard Group Inc Valley Forge, PA10.2MShares$418 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.03MShares$248 Million0.01% of portfolio
-
State Street Corp Boston, MA4.67MShares$192 Million0.01% of portfolio
-
Jpmorgan Chase & CO New York, NY2.12MShares$87.1 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.87MShares$77.2 Million0.01% of portfolio
About Viking Therapeutics, Inc.
- Ticker VKTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,688,496
- Market Cap $3.16B
- Description
- Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endocrine disorders. The company's lead drug candidate is VK2809, an orally available tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß), which is in Phase IIb clinical trial...